Learn about a clinical trial to evaluate a new
investigational medicine that may help reduce
seizures in adults.
Who can participate in this study?
- Age between 18 and 75 years
- Participant and/or caregiver self-reports at least countable generalized tonic-clonic seizures within the last 8 weeks
- Currently receiving 1-3 allowable ASMs (Anti-Seizure Medications) with stable doses for at least 4 weeks
- See the image below for more information